Dundee, United Kingdom

Mark Thomas



Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Mark Thomas

Introduction

Mark Thomas is a notable inventor based in Dundee, GB. He has made significant contributions to the field of pharmaceuticals, holding two patents that focus on innovative compounds for treating various medical conditions.

Latest Patents

His latest patents include Pyrimidin-4-yl-3, 4-dihydro-2H-pyrrolo [1,2A] pyrazin-1-one compounds. This invention relates to compounds that can be used in pharmaceutical compositions for treating proliferative disorders, viral disorders, and strokes. Another patent involves Thiazolo-, oxazalo, and imidazolo-quinazoline compounds capable of inhibiting protein kinases. These compounds are also aimed at treating a range of disorders, including CNS disorders, diabetes, and cardiovascular issues.

Career Highlights

Mark Thomas is currently associated with Cyclacel Limited, where he continues to work on groundbreaking pharmaceutical innovations. His research focuses on developing new therapeutic agents that can significantly improve patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Campbell McInnes and Shudong Wang, contributing to the advancement of their shared research goals.

Conclusion

Mark Thomas is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various serious health conditions. His innovative spirit and dedication to research continue to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…